<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.0 20120330//EN" "JATS-journalpublishing1.dtd">
<article article-type="research-article" dtd-version="1.0" xml:lang="hr" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">LV</journal-id>
<journal-id journal-id-type="nlm-ta">Lijec Vjesn</journal-id>
<journal-title-group>
<journal-title>Lijecnicki Vjesnik</journal-title>
<abbrev-journal-title abbrev-type="pubmed">Lijec. Vjesn.</abbrev-journal-title>
</journal-title-group>
<issn pub-type="ppub">0024-3477</issn>
<issn pub-type="epub">1849-2177</issn>
<publisher><publisher-name>Croatian Medical Association</publisher-name></publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="publisher-id">LV-146-130</article-id>
<article-id pub-id-type="doi">10.26800/LV-146-3-4-5</article-id>
<article-categories><subj-group subj-group-type="heading"><subject>Original article</subject></subj-group>
</article-categories>
<title-group>
<article-title>Deset godina programa postavljanja dijaliznih katetera u Zavodu za nefrologiju Klini&#x010D;ke bolnice Merkur &#x2013; izvje&#x0161;&#x0107;e jednog sredi&#x0161;ta</article-title>
<trans-title-group xml:lang="en">
<trans-title>Ten-year experience in dialysis catheter placement in the Division of Nephrology of the Clinical Hospital Merkur &#x2013; single center report</trans-title>
</trans-title-group>
</title-group>
<contrib-group>
<contrib contrib-type="author"><name><surname>&#x010C;ingel</surname><given-names>Branislav</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author"><name><surname>Maksimovi&#x0107;</surname><given-names>Bojana</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref><xref ref-type="aff" rid="aff2"><sup>2</sup></xref></contrib><contrib contrib-type="author"><name><surname>Zibar</surname><given-names>Lada</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref><xref ref-type="aff" rid="aff3"><sup>3</sup></xref></contrib><contrib contrib-type="author"><name><surname>Margeta</surname><given-names>Ivan</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author"><name><surname>&#x0160;ulc</surname><given-names>Snje&#x017E;ana</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author"><name><surname>Jurekovi&#x0107;</surname><given-names>&#x017D;eljka</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author"><name><surname>&#x0160;imunov</surname><given-names>Bojana</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author"><name><surname>Vu&#x010D;ur &#x0160;imi&#x0107;</surname><given-names>Ksenija</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author"><name><surname>Canjuga Sever</surname><given-names>Iva</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author"><name><surname>Boras</surname><given-names>Karla</given-names></name><xref ref-type="aff" rid="aff4"><sup>4</sup></xref></contrib><contrib contrib-type="author"><name><surname>Knotek</surname><given-names>Mladen</given-names></name><xref ref-type="aff" rid="aff5"><sup>5</sup></xref></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-0240-4178</contrib-id><name><surname>Laganovi&#x0107;</surname><given-names>Mario</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref><xref ref-type="aff" rid="aff2"><sup>2</sup></xref></contrib>
<aff id="aff1"><label>1</label><institution>Klini&#x010D;ka bolnica Merkur</institution>, <addr-line>Zagreb</addr-line></aff>
<aff id="aff2"><label>2</label><institution>Medicinski fakultet Sveu&#x010D;ili&#x0161;ta u Zagrebu</institution>, <addr-line>Zagreb</addr-line></aff>
<aff id="aff3"><label>3</label><institution>Medicinski fakultet Sveu&#x010D;ili&#x0161;ta Josipa Jurja Strossmayera u Osijeku</institution>, <addr-line>Osijek</addr-line></aff>
<aff id="aff4"><label>4</label><institution>Ordinacija obiteljske medicine dr. Tamara Perleta Stambolija</institution>, <addr-line>Zagreb</addr-line></aff>
<aff id="aff5"><label>5</label>Tree Top Hospital, Dhumburi Magu Hulhumale&#x2019;, Republic of Maldives</aff>
</contrib-group>
<author-notes>
<corresp id="cor1">Adresa za dopisivanje: Izv. prof. dr. sc. Mario Laganovi&#x0107;, dr. med., <ext-link ext-link-type="uri" xlink:href="https://orcid.org/0000-0002-0240-4178">https://orcid.org/0000-0002-0240-4178</ext-link>, Zavod za nefrologiju, Klinika za unutarnje bolesti, Klini&#x010D;ka bolnica Merkur, Zaj&#x010D;eva 19, 10000 Zagreb, e-po&#x0161;ta: <email xlink:href="mlaganovic@gmail.com">mlaganovic@gmail.com</email></corresp>
<fn fn-type="con">
<p content-type="fn-title">DOPRINOS AUTORA</p>
<p>K<sc>oncepcija</sc> <sc>ili</sc> <sc>nacrt</sc> <sc>rada</sc>: B&#x010C;, BM, LZ, IM, S&#x0160;, &#x017D;J, B&#x0160;, KV&#x0160;, ICS, KB, MK, ML</p>
<p>P<sc>rikupljanje</sc>, <sc>analiza</sc> <sc>i</sc> <sc>interpretacija</sc> <sc>podataka</sc>: B&#x010C;, BM, LZ, IM, S&#x0160;, &#x017D;J, B&#x0160;, KV&#x0160;, ICS, KB, MK, ML</p>
<p>P<sc>isanje</sc> <sc>prve</sc> <sc>verzije</sc> <sc>rada</sc>: B&#x010C;, BM, LZ, IM, S&#x0160;, &#x017D;J, B&#x0160;, KV&#x0160;, ICS, KB, MK, ML</p>
<p>K<sc>riti&#x010D;ka</sc> <sc>revizija</sc>: B&#x010C;, LZ, IM, KV&#x0160;, ML</p>
</fn>
</author-notes>
<pub-date date-type="pub" publication-format="electronic"><month>06</month><year>2024</year></pub-date>
<pub-date date-type="pub" publication-format="print"><month>06</month><year>2024</year></pub-date>
<volume>146</volume>
<issue>3-4</issue>
<fpage>130</fpage>
<lpage>133</lpage>
<permissions>
<copyright-statement>Croatian Medical Association</copyright-statement>
<copyright-year>2024</copyright-year>
<copyright-holder>Croatian Medical Association</copyright-holder>
<license xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/" specific-use="CC BY-NC-ND 4.0"><license-p>This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial No Derivatives (CC BY-NC-ND) 4.0 License.</license-p></license>
</permissions>
<abstract>
<title>SA&#x017D;ETAK</title>
<p>Hemodijaliza (HD) je naj&#x010D;e&#x0161;&#x0107;a metoda nadomje&#x0161;tanja bubre&#x017E;ne funkcije u svijetu. Tunelirani dijalizni kateteri (TDK) predstavljaju jednu od naj&#x010D;e&#x0161;&#x0107;e kori&#x0161;tenih mogu&#x0107;nosti u osiguravanju &#x017E;ilnog pristupa za HD. Cilj retrospektivnog istra&#x017E;ivanja bio je prikazati desetogodi&#x0161;nje iskustvo u postavljanju dijaliznih katetera u na&#x0161;em sredi&#x0161;tu. U razdoblju od 2012. do 2021. godine postavljeno je 1.660 dijaliznih katetera, od kojih su 80% bili TDK. Naj&#x010D;e&#x0161;&#x0107;e mjesto pristupa bila je desna unutarnja jugularna vena, potom lijeva unutarnja jugularna vena, femoralne vene te subklavijske vene. Svim bolesnicima dijalizni kateter je uspje&#x0161;no postavljen, a u postupcima je sudjelovalo dvanaest lije&#x010D;nika Zavoda za nefrologiju, od &#x010D;ega je sedam lije&#x010D;nika postavilo 89% svih katetera, a &#x010D;etvero lije&#x010D;nika ima vi&#x0161;e od 300 postavljenih dijaliznih katetera po osobi. Zaklju&#x010D;no mo&#x017E;emo re&#x0107;i da organizirani programi postavljanja katetera osiguravaju velik broj bolesnika i iskustvo operaterima za u&#x010D;inkovito postizanje &#x017E;ilnog pristupa i najslo&#x017E;enijim bolesnicima.</p>
</abstract>
<trans-abstract xml:lang="en">
<title>SUMMARY</title>
<p>Heamodialysis (HD) is the most common modality of renal replacement therapy in the world. Tunneled dialysis catheters (TDC) are one of the most utilized vascular access options for HD. The aim of this study was to present a ten-year experience in HD catheter placement in our centre. During the period from 2012 to 2021 a total of 1 660 HD catheters were placed, of which 80% were TDCs. The most common place of insertion was the right internal jugular vein (JV), followed by the left internal JV, femoral veins, and subclavian veins. In all patients HD catheter was successfully placed. Twelve doctors in the Division of Nephrology were engaged in HD catheter placement, seven of them were responsible for 89% of HD catheters placed, and four of them had experience of more than 300 HD catheter placements. We can conclude that organized HD catheter programs provide a large pool of patients and experience for doctors in vascular access managing for even the most difficult patients.</p>
</trans-abstract>
<kwd-group kwd-group-type="author"><kwd>Deskriptori KRONI&#x010C;NA BUBRE&#x017D;NA BOLEST &#x2013; lije&#x010D;enje</kwd><kwd>HEMODIJALIZA &#x2013; metode</kwd><kwd>SREDI&#x0160;NJI VENSKI KATETERI &#x2013; statisti&#x010D;ki podatci</kwd><kwd>JUGULARNE VENE</kwd><kwd>ISHOD LIJE&#x010C;ENJA</kwd><kwd>RETROSPEKTIVNA ISTRA&#x017D;IVANJA</kwd></kwd-group>
<kwd-group kwd-group-type="translator" xml:lang="en"><title>Descriptors </title><kwd>KIDNEY FAILURE, CHRONIC &#x2013; therapy</kwd><kwd>RENAL DIALYSIS &#x2013; methods</kwd><kwd>CENTRAL VENOUS CATHETERS &#x2013; statistics and numerical data</kwd><kwd>JUGULAR VEINS</kwd><kwd>TREATMENT OUTCOME</kwd><kwd>RETROSPECTIVE STUDIES</kwd></kwd-group>
</article-meta>
</front>
<body>
<p>Kroni&#x010D;na bubre&#x017E;na bolest (KBB) je napreduju&#x0107;a bolest od koje boluje vi&#x0161;e od 800 milijuna osoba u svijetu te predstavlja jedan od vode&#x0107;ih uzroka smrti. (<xref ref-type="bibr" rid="r1"><italic>1</italic></xref>) Prevalencija KBB-a je u porastu, posebice me&#x0111;u oboljelima od hipertenzije i &#x0161;e&#x0107;erne bolesti. (<xref ref-type="bibr" rid="r1"><italic>1</italic></xref>, <xref ref-type="bibr" rid="r2"><italic>2</italic></xref>) Procjenjuje se da vi&#x0161;e od dva milijuna bolesnika sa zavr&#x0161;nim stupnjem KBB-a treba nadomje&#x0161;tanje bubre&#x017E;ne funkcije (NBF). (<xref ref-type="bibr" rid="r3"><italic>3</italic></xref>) Prema podatcima iz registra Europskog udru&#x017E;enja za nefrologiju, dijalizu i transplantaciju (ERA-EDTA) prevalencija NBF-a iznosila je 1.040 na milijun stanovnika, a 56% bolesnika istu je nadomje&#x0161;talo hemodijalizom (HD). (<xref ref-type="bibr" rid="r2"><italic>2</italic></xref>) Iako je poznato da je presadba bubrega najbolja metoda NBF-a, 2010. godine vi&#x0161;e od 80% bolesnika u svijetu bubre&#x017E;nu je funkciju nadomje&#x0161;talo HD-om. (<xref ref-type="bibr" rid="r4"><italic>4</italic></xref>) Mogu&#x0107;nosti &#x017E;ilnog pristupa za HD su arterijskovenska fistula (AVF), arterijskovenski graft (AVG) i sredi&#x0161;nji venski kateter (SVK) koji mo&#x017E;e biti netunelirani (privremeni) ili tunelirani (trajni, s tzv. <italic>cuffom</italic>). (<xref ref-type="bibr" rid="r5"><italic>5</italic></xref>) Otprilike 65% bolesnika zapo&#x010D;inje kroni&#x010D;ni HD putem SVK-a. (<xref ref-type="bibr" rid="r6"><italic>6</italic></xref>) Unato&#x010D; &#x010D;injenici da AVF ima prednost pred AVG-om i SVK-om, postavljanje tuneliranih dijaliznih katetera (TDK) predstavlja va&#x017E;an postupak u zbrinjavanju ove skupine bolesnika. (<xref ref-type="bibr" rid="r4"><italic>4</italic></xref>, <xref ref-type="bibr" rid="r5"><italic>5</italic></xref>, <xref ref-type="bibr" rid="r7"><italic>7</italic></xref>) TDK se naj&#x010D;e&#x0161;&#x0107;e postavlja u osoba s vi&#x0161;estrukim pridru&#x017E;enim bolestima, kra&#x0107;im o&#x010D;ekivanim trajanjem &#x017E;ivota, nemogu&#x0107;no&#x0161;&#x0107;u kreiranja AVF-a ili AVG-a te iscrpljenim drugim mogu&#x0107;nostima &#x017E;ilnog pristupa. (<xref ref-type="bibr" rid="r5"><italic>5</italic></xref>) Prednosti SVK-a u odnosu na AVF i AVG uklju&#x010D;uju tehni&#x010D;ki manje zahtjevan i jeftiniji postupak, mogu&#x0107;nost zapo&#x010D;injanja HD-a bez odgode i bez potrebe za perkutanim kanuliranjem prilikom dijaliznog postupka. (<xref ref-type="bibr" rid="r5"><italic>5</italic></xref>, <xref ref-type="bibr" rid="r7"><italic>7</italic></xref>) Smjernice preporu&#x010D;uju desnu unutarnju jugularnu venu (JV) kao prvi izbor za pristup postavljanju TDK-a, a potom slijede lijevi unutarnji JV, vanjski JV, femoralna vena, te subklavijska vena. (<xref ref-type="bibr" rid="r5"><italic>5</italic></xref>) Kada su ovi &#x017E;ilni pristupi iscrpljeni u obzir dolazi postavljanje TDK-a translumbalnim pristupom u donju &#x0161;uplju venu, transhepati&#x010D;nim pristupom u hepati&#x010D;nu venu u slu&#x010D;aju okluzije infrarenalne donje &#x0161;uplje vene ili postavljanje TDK-a u venu azygos. (<xref ref-type="bibr" rid="r5"><italic>5</italic></xref>, <xref ref-type="bibr" rid="r7"><italic>7</italic></xref>) Ponekad, s ciljem o&#x010D;uvanja infrarenalne donje &#x0161;uplje vene i ilija&#x010D;nih vena u osoba koje su kandidati za presadbu bubrega, transrenalni pristup za postavljanje TDK-a predstavlja jednu od mogu&#x0107;nosti. (<xref ref-type="bibr" rid="r7"><italic>7</italic></xref>) Prema studiji uspje&#x0161;nost postavljanja TDK-a pod kontrolom ultrazvuka iznosila je 97%. (<xref ref-type="bibr" rid="r8"><italic>8</italic></xref>) S obzirom na osobine bolesnika, dob, pridru&#x017E;ene bolesti i stanje &#x017E;ilja potrebna je vje&#x0161;tina u postavljanju katetera kako bi se bolesniku osigurao dijalizni put i pravovremeno po&#x010D;elo s postupkom HD-a. U ovom pregledu donosimo rezultate desetogodi&#x0161;njeg iskustva u postavljanju dijaliznih katetera u Zavodu za nefrologiju Klini&#x010D;ke bolnice Merkur.</p>
<sec sec-type="other1">
<title>Postupci</title>
<p>U retrospektivno kohortno istra&#x017E;ivanje uklju&#x010D;eni su svi bolesnici sa zavr&#x0161;nim stupnjem KBB-a kojima je postavljen dijalizni kateter u Zavodu za nefrologiju, u Klini&#x010D;koj bolnici Merkur, u razdoblju od 2012. do 2021. godine. Obuhva&#x0107;eni su bolesnici kojima je dijalizni kateter postavljen prvi put, kao i oni s vi&#x0161;estrukim &#x017E;ilnim komplikacijama koji nisu mogli biti zbrinuti u drugim ustanovama. Analizirani podatci uklju&#x010D;ivali su demografske podatke o bolesnicima, vrstu postavljenoga dijaliznog katetera (netunelirani ili tunelirani), vrstu TDK (Hickman<sup>&#x00AE;</sup> ili Tesio<sup>&#x00AE;</sup>), mjesto postavljanja dijaliznog katetera, te dijalizno sredi&#x0161;te iz kojega je bolesnik upu&#x0107;en na postavljanje dijaliznog katetera. Istra&#x017E;ivanje je provedeno u skladu s eti&#x010D;kim na&#x010D;elima Deklaracije iz Helsinkija.</p>
<p>U statisti&#x010D;koj analizi kontinuirane varijable izra&#x017E;ene su kao medijan (minimum &#x2013; maksimum), a kategorijske varijable kao apsolutni brojevi (postotci).</p>
</sec>
<sec sec-type="other2">
<title>Rezultati</title>
<p>Tijekom desetogodi&#x0161;njeg razdoblja postavljeno je 1.660 dijaliznih katetera. Najvi&#x0161;e dijaliznih katetera postavljeno je 2016. godine (N = 195), a najmanje 2014. godine (N = 134). Dijalizni kateteri &#x010D;e&#x0161;&#x0107;e su postavljeni u mu&#x0161;karaca nego u &#x017E;ena (52% naspram 48%). Raspodjela dijaliznih katetera po godinama prema spolu i dobi prikazana je na <xref ref-type="fig" rid="f1A">Figure 1A</xref> i <xref ref-type="fig" rid="f1B">Figure 1B</xref>. Medijan dobi bolesnika pri postavljanju katetera bio je 67 godina (minimum &#x2013; maksimum: 16 &#x2013; 97 godina). Od ukupnog broja postavljenih dijaliznih katetera 80% su bili TDK, a 20% netunelirani dijalizni kateteri. Hickmanov kateter postavljen je u 96% bolesnika, a Tesio kateter u 4% bolesnika. U 86% bolesnika kateter je postavljen pristupom u jednu od vena sliva gornje &#x0161;uplje vene, koriste&#x0107;i naj&#x010D;e&#x0161;&#x0107;e desni unutarnji JV (54%). U 14,9% bolesnika kori&#x0161;ten je femoralni pristup za postavljanje dijaliznog katetera, a 0,9% bolesnika nije imalo mogu&#x0107;nost postavljanja dijaliznog katetera niti jednim od gore navedenih pristupa te je kateter postavljen alternativnim pristupom (donja &#x0161;uplja vena, vena brahijalis ili vena basilika). Raspodjela dijaliznih katetera prema mjestu pristupa prikazana je na <xref ref-type="fig" rid="f2">Figure 2</xref>. U navedenom razdoblju bolesnici su upu&#x0107;eni iz 35 dijaliznih sredi&#x0161;ta Republike Hrvatske te iz tri sredi&#x0161;ta iz Bosne i Hercegovine. Svim bolesnicima koji su do sada hospitalizirani u KB-u Merkur uspje&#x0161;no je postavljen prikladan dijalizni put. Tijekom godina ukupno dvanaest lije&#x010D;nika Zavoda sudjelovalo je u postavljanju dijaliznih katetera, od &#x010D;ega je sedam lije&#x010D;nika postavilo 89% svih katetera, a &#x010D;etvero lije&#x010D;nika je postavilo vi&#x0161;e od 300 dijaliznih katetera po osobi.</p>
<fig id="f1A" position="float" fig-type="figure"><label>Figure 1A</label><caption><p>Distribution of catheter placement by year and gender</p></caption><graphic xlink:href="LV-146-130-f1A"></graphic></fig>
<fig id="f1B" position="float" fig-type="figure"><label>Figure 1B</label><caption><p>Distribution of catheter placement by year and age</p></caption><graphic xlink:href="LV-146-130-f1B"></graphic></fig>
<fig id="f2" position="float" fig-type="figure"><label>Figure 2</label><caption><p>Distribution of catheter placement according to insertion site Legenda/Legend: DJV/RJV &#x2013; desna jugularna vena / right jugular vien, LJV &#x2013; lijeva jugularna vena / left jugular vein, DFV/RFV &#x2013; desna femoralna vena / right femoral vein, LFV &#x2013; lijeva femoralna vena / left femoral vein, DSV/RSV &#x2013; desna subklavijalna vena / right subclavian vein, LSV &#x2013; lijeva subklavijalna vena / left subclavian vein</p></caption><graphic xlink:href="LV-146-130-f2"></graphic></fig>
</sec>
<sec sec-type="other3">
<title>Rasprava</title>
<p>Ovo retrospektivno istra&#x017E;ivanje prikazuje analizu vi&#x0161;egodi&#x0161;njeg iskustva jednoga nefrolo&#x0161;kog sredi&#x0161;ta u postavljanju dijaliznih katetera. U posljednjem desetlje&#x0107;u prevalencija zavr&#x0161;nog stupnja KBB-a je u porastu, pri &#x010D;emu je HD naj&#x010D;e&#x0161;&#x0107;a metoda NBF-a, a osiguravanje &#x017E;ilnog pristupa za HD jedan je od najve&#x0107;ih izazova. (<xref ref-type="bibr" rid="r1"><italic>1</italic></xref>, <xref ref-type="bibr" rid="r9"><italic>9</italic></xref>, <xref ref-type="bibr" rid="r10"><italic>10</italic></xref>) Iako je AVF preferirani izbor za &#x017E;ilni pristup, TDK ima va&#x017E;nu ulogu u osiguravanju pristupa za HD u odre&#x0111;enih bolesnika. (<xref ref-type="bibr" rid="r5"><italic>5</italic></xref>) Tijekom desetogodi&#x0161;njeg razdoblja u na&#x0161;em sredi&#x0161;tu postavljeno je vi&#x0161;e od 1.500 dijaliznih katetera, od kojih su ve&#x0107;ina bili TDK. Medijan dobi bolesnika bio je 67 godina, a udio mu&#x0161;karaca je bio ne&#x0161;to ve&#x0107;i u odnosu na udio &#x017E;ena, &#x0161;to je sli&#x010D;no izvje&#x0161;&#x0107;ima drugih autora. (<xref ref-type="bibr" rid="r11"><italic>11</italic></xref>, <xref ref-type="bibr" rid="r12"><italic>12</italic></xref>) Kada smo analizirali mjesto pristupa, dijalizni kateter naj&#x010D;e&#x0161;&#x0107;e je postavljen pristupom kroz desni unutarnji JV (54%), potom lijevi unutarnji JV (19%), femoralnu venu (15%) te najrje&#x0111;e putem vene subklavije (11%). Prema va&#x017E;e&#x0107;im smjernicama <italic>Kidney Disease Outcomes Quality Initiative</italic> (KDOQI) vanjska JV tako&#x0111;er je jedna od mogu&#x0107;nosti za &#x017E;ilni pristup, ali to u na&#x0161;em sredi&#x0161;tu nije bila praksa. (<xref ref-type="bibr" rid="r5"><italic>5</italic></xref>) Pristup putem desnoga unutarnjeg JV-a je preferabilan zbog anatomskih osobitosti i manjeg rizika komplikacija, &#x0161;to je i kori&#x0161;teno u vi&#x0161;e od polovice na&#x0161;ih bolesnika. (<xref ref-type="bibr" rid="r5"><italic>5</italic></xref>, <xref ref-type="bibr" rid="r7"><italic>7</italic></xref>) Sli&#x010D;no na&#x0161;im rezultatima, u istra&#x017E;ivanju koje je uklju&#x010D;ilo 812 bolesnika kojima je postavljen TDK, desni JV kori&#x0161;ten je u 64% bolesnika, lijevi JV u 20% bolesnika, femoralna vena u 15% bolesnika, dok je subklavijska vena kori&#x0161;tena u manjeg broja bolesnika (1%). (<xref ref-type="bibr" rid="r11"><italic>11</italic></xref>) U navedenom istra&#x017E;ivanju, kao i u na&#x0161;emu, bili su uklju&#x010D;eni bolesnici kojima je dijalizni kateter postavljen prvi put, kao i oni s vi&#x0161;estrukim postupcima postavljanja katetera, pri &#x010D;emu su u na&#x0161;em istra&#x017E;ivanju bili uklju&#x010D;eni i bolesnici s netuneliranim dijaliznim kateterom. (<xref ref-type="bibr" rid="r11"><italic>11</italic></xref>) Me&#x0111;u tri anatomske lokacije (jugularna, femoralna, subklavijska), u istra&#x017E;ivanju Bella i suradnika provedenome na 1.176 SVK-a, u 64% slu&#x010D;ajeva kateter je postavljen u jedan od unutarnjih JV-a, u 20% slu&#x010D;ajeva u subklavijsku venu, a u 18% slu&#x010D;ajeva u femoralnu venu. (<xref ref-type="bibr" rid="r12"><italic>12</italic></xref>) U na&#x0161;em istra&#x017E;ivanju u 1% bolesnika u kojih su bili iscrpljeni standardni &#x017E;ilni pristupi kori&#x0161;ten je alternativni pristup, uklju&#x010D;uju&#x0107;i donju &#x0161;uplju venu, venu basiliku ili venu brahijalis. Izbor &#x017E;ilnog pristupa (vrsta i mjesto) treba biti individualno razmatran te osigurati dobar dijalizni put koji &#x0107;e omogu&#x0107;iti bolesniku kvalitetan HD. Ovim istra&#x017E;ivanjem pokazali smo dobro iskustvo na&#x0161;eg sredi&#x0161;ta u postavljanju dijaliznih katetera, &#x0161;to pokazuje ne samo velik broj postavljenih dijaliznih katetera, nego i podatak da je svim bolesnicima kateter uspje&#x0161;no postavljen, &#x0161;to je usporedivo s prethodno objavljenim izvje&#x0161;&#x0107;em K&#x00E4;chele i suradnika. (<xref ref-type="bibr" rid="r8"><italic>8</italic></xref>) Istra&#x017E;ivanje ima odre&#x0111;ene nedostatke, uklju&#x010D;uju&#x0107;i retrospektivan ustroj te izostanak pra&#x0107;enja bolesnika nakon postavljanja katetera.</p>
</sec>
<sec sec-type="other4">
<title>Zaklju&#x010D;ak</title>
<p>Postavljanje TDK-a je invazivni postupak koji zahtijeva iskusnog lije&#x010D;nika i pa&#x017E;ljivu tehniku kako bi se izbjegle komplikacije koje mogu biti &#x017E;ivotno ugro&#x017E;avaju&#x0107;e. U KB Merkur je dugogodi&#x0161;nje postavljanje TDK-a uklju&#x010D;ivalo velik broj bolesnika, uporabu razli&#x010D;itih &#x017E;ila za pristup i u potpunosti uspje&#x0161;an neposredan ishod. Organizirani programi postavljanja katetera osiguravaju velik broj bolesnika i iskustvo operaterima za u&#x010D;inkovito omogu&#x0107;avanje &#x017E;ilnog pristupa i najslo&#x017E;enijim bolesnicima.</p>
</sec>
</body>
<back>
<fn-group>
<fn fn-type="conflict">
<p content-type="fn-title">INFORMACIJE O SUKOBU INTERESA</p>
<p>Autori nisu deklarirali sukob interesa relevantan za ovaj rad.</p>
</fn>
<fn fn-type="financial-disclosure">
<p content-type="fn-title">INFORMACIJA O FINANCIRANJU</p>
<p>Za ovaj &#x010D;lanak nisu primljena financijska sredstva.</p>
</fn>
</fn-group>
<ref-list>
<title>LITERATURA</title>
<ref id="r1"><label>1</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kovesdy</surname><given-names>CP</given-names></name></person-group>. <article-title>Epidemiology of chronic kidney disease: an update 2022.</article-title> <source>Kidney Int Suppl (2011)</source>. <year>2022</year>;<volume>12</volume>(<issue>1</issue>):<fpage>7</fpage>&#x2013;<lpage>11</lpage>.<pub-id pub-id-type="pmid">35529086</pub-id></mixed-citation></ref>
<ref id="r2"><label>2</label><mixed-citation publication-type="other">Boerstra BA, Boenink R, Astley ME, Bonthuis M, El Hafeez SA, Monz&#x00F3;n FA, et al. The ERA Registry Annual Report 2021: a summary. Clin Kidney J. 2023;17(2):sfad28.</mixed-citation></ref>
<ref id="r3"><label>3</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Philipponnet</surname><given-names>C</given-names></name><name><surname>Aniort</surname><given-names>J</given-names></name><name><surname>Pereira</surname><given-names>B</given-names></name><name><surname>Azarnouch</surname><given-names>K</given-names></name><name><surname>Hadj-Abdelkader</surname><given-names>M</given-names></name><name><surname>Chabrot</surname><given-names>P</given-names></name><etal/></person-group> <article-title>Systematic Review of Atrial Vascular Access for Dialysis Catheter.</article-title> <source>Kidney Int Rep</source>. <year>2020</year>;<volume>5</volume>:<fpage>1000</fpage>&#x2013;<lpage>6</lpage>. <pub-id pub-id-type="doi">10.1016/j.ekir.2020.04.006</pub-id><pub-id pub-id-type="pmid">32647757</pub-id></mixed-citation></ref>
<ref id="r4"><label>4</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Thurlow</surname><given-names>JS</given-names></name><name><surname>Joshi</surname><given-names>M</given-names></name><name><surname>Yan</surname><given-names>G</given-names></name><name><surname>Norris</surname><given-names>KC</given-names></name><name><surname>Agodoa</surname><given-names>LY</given-names></name><name><surname>Yuan</surname><given-names>CM</given-names></name><etal/></person-group> <article-title>Global Epidemiology of End-Stage Kidney Disease and Disparities in Kidney Replacement Therapy.</article-title> <source>Am J Nephrol</source>. <year>2021</year>;<volume>52</volume>:<fpage>98</fpage>&#x2013;<lpage>107</lpage>. <pub-id pub-id-type="doi">10.1159/000514550</pub-id><pub-id pub-id-type="pmid">33752206</pub-id></mixed-citation></ref>
<ref id="r5"><label>5</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lok</surname><given-names>CE</given-names></name><name><surname>Huber</surname><given-names>TS</given-names></name><name><surname>Lee</surname><given-names>T</given-names></name><name><surname>Shenoy</surname><given-names>S</given-names></name><name><surname>Yevzlin</surname><given-names>AS</given-names></name><name><surname>Abreo</surname><given-names>K</given-names></name><etal/></person-group> <article-title>KDOQI Clinical Practice Guideline for Vascular Access. 2019 Update.</article-title> <source>Am J Kidney Dis</source>. <year>2020</year>;<volume>75</volume>:<fpage>S1</fpage>&#x2013;<lpage>164</lpage>. <pub-id pub-id-type="doi">10.1053/j.ajkd.2019.12.001</pub-id><pub-id pub-id-type="pmid">32778223</pub-id></mixed-citation></ref>
<ref id="r6"><label>6</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pisoni</surname><given-names>RL</given-names></name><name><surname>Young</surname><given-names>EW</given-names></name><name><surname>Dykstra</surname><given-names>DM</given-names></name><name><surname>Greenwood</surname><given-names>RN</given-names></name><name><surname>Hecking</surname><given-names>E</given-names></name><name><surname>Gillespie</surname><given-names>B</given-names></name><etal/></person-group> <article-title>Vascular access use in Europe and the United States: results from the DOPPS.</article-title> <source>Kidney Int</source>. <year>2002</year>;<volume>61</volume>:<fpage>305</fpage>&#x2013;<lpage>16</lpage>. <pub-id pub-id-type="doi">10.1046/j.1523-1755.2002.00117.x</pub-id><pub-id pub-id-type="pmid">11786113</pub-id></mixed-citation></ref>
<ref id="r7"><label>7</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sharma</surname><given-names>M</given-names></name><name><surname>Tong</surname><given-names>WL</given-names></name><name><surname>Thompson</surname><given-names>D</given-names></name><name><surname>Vachharajani</surname><given-names>TJ</given-names></name></person-group>. <article-title>Placing an appropriate tunneled dialysis catheter in an appropriate patient including the nonconventional sites.</article-title> <source>Cardiovasc Diagn Ther</source>. <year>2023</year>;<volume>13</volume>:<fpage>281</fpage>&#x2013;<lpage>90</lpage>. <pub-id pub-id-type="doi">10.21037/cdt-22-426</pub-id><pub-id pub-id-type="pmid">36864971</pub-id></mixed-citation></ref>
<ref id="r8"><label>8</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>K&#x00E4;chele</surname><given-names>M</given-names></name><name><surname>Bettac</surname><given-names>L</given-names></name><name><surname>Hofmann</surname><given-names>C</given-names></name><name><surname>Herrmann</surname><given-names>H</given-names></name><name><surname>Brandt</surname><given-names>A</given-names></name><name><surname>Schr&#x00F6;ppel</surname><given-names>B</given-names></name><etal/></person-group> <article-title>Feasibility Analysis of Ultrasound-Guided Placement of Tunneled Hemodialysis Catheters.</article-title> <source>Kidney Int Rep</source>. <year>2023</year>;<volume>8</volume>:<fpage>2001</fpage>&#x2013;<lpage>7</lpage>. <pub-id pub-id-type="doi">10.1016/j.ekir.2023.07.038</pub-id><pub-id pub-id-type="pmid">37849990</pub-id></mixed-citation></ref>
<ref id="r9"><label>9</label><mixed-citation publication-type="other">Pereira K, Osiason A, Salsamendi J. Vascular Access for Placement of Tunneled Dialysis Catheters for Hemodialysis: A Systematic Approach and Clinical Practice Algorithm. J Clin Imaging Sci. 201529;5:31.</mixed-citation></ref>
<ref id="r10"><label>10</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Agarwal</surname><given-names>AK</given-names></name><name><surname>Haddad</surname><given-names>N</given-names></name><name><surname>Boubes</surname><given-names>K</given-names></name></person-group>. <article-title>Avoiding problems in tunneled dialysis catheter placement.</article-title> <source>Semin Dial</source>. <year>2019</year>;<volume>32</volume>:<fpage>535</fpage>&#x2013;<lpage>40</lpage>. <pub-id pub-id-type="doi">10.1111/sdi.12845</pub-id><pub-id pub-id-type="pmid">31710156</pub-id></mixed-citation></ref>
<ref id="r11"><label>11</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fry</surname><given-names>AC</given-names></name><name><surname>Stratton</surname><given-names>J</given-names></name><name><surname>Farrington</surname><given-names>K</given-names></name><name><surname>Mahna</surname><given-names>K</given-names></name><name><surname>Selvakumar</surname><given-names>S</given-names></name><name><surname>Thompson</surname><given-names>H</given-names></name><etal/></person-group> <article-title>Factors affecting long-term survival of tunnelled haemodialysis catheters &#x2013; a prospective audit of 812 tunnelled catheters.</article-title> <source>Nephrol Dial Transplant</source>. <year>2008</year>;<volume>23</volume>:<fpage>275</fpage>&#x2013;<lpage>81</lpage>. <pub-id pub-id-type="doi">10.1093/ndt/gfm582</pub-id><pub-id pub-id-type="pmid">17890252</pub-id></mixed-citation></ref>
<ref id="r12"><label>12</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bell</surname><given-names>J</given-names></name><name><surname>Goyal</surname><given-names>M</given-names></name><name><surname>Long</surname><given-names>S</given-names></name><name><surname>Kumar</surname><given-names>A</given-names></name><name><surname>Friedrich</surname><given-names>J</given-names></name><name><surname>Garfinkel</surname><given-names>J</given-names></name><etal/></person-group> <article-title>Anatomic Site-Specific Complication Rates for Central Venous Catheter Insertions.</article-title> <source>J Intensive Care Med</source>. <year>2020</year>;<volume>35</volume>:<fpage>869</fpage>&#x2013;<lpage>74</lpage>. <pub-id pub-id-type="doi">10.1177/0885066618795126</pub-id><pub-id pub-id-type="pmid">30231668</pub-id></mixed-citation></ref>
</ref-list>
</back>
</article>
